Reply To: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios

  • Julie Juno-Lapan

    August 30, 2022 at 12:47 pm

    We staff dinutuximab patients 2:1 (2 patients : 1 nurse) while the chimeric is infusing.  We staff 3:1 in between doses if patient is stable.

    For Blin, we staff 2:1 for initial infusion and until patient is deemed stable

    Both are driven by frequency of vital signs, dose changes, patient stability and pain control

    Julie Juno-LaPan, MS,RN-BC, CNML
    Clinical Nursing Director 7 East
    Pediatric PHO/BMT
    CS Mott Children’s Hospital
    Ann Arbor, MIchigan
    Original Message:
    Sent: 08-30-2022 11:38 AM
    From: Erin Jones
    Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios

    Hi Alyssa,

    I’m in the very same boat right now defending all of our staffing ratios, but especially anything 2:1. I have not been able to find much at all in regards to staffing ratios for pediatric oncology patients, much less staffing ratios for specific therapies, in a literature review. The comments I’ve found here have been my best resource so far, but if you find others, please share!

    We put Dinatuxumab patients in a 2:1 assignment, though staffing constraints continue to make that very challenging. They are usually on a ketamine drip with our pain team managing that component.  Our blinatumomab patients we staff in a 3:1 ratio. I hope you get a robust number of responses to this thread because benchmarking would be helpful!

    Erin Jones, MHA, BSN, RN, CCRN-K | Patient Services Manager III
    5 Children’s | Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cardiology
    NC Children’s Hospital
    UNC Health
    Chapel Hill, NC

    Original Message:
    Sent: 08-30-2022 07:34 AM
    From: Alyssa Henderson
    Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios

    Hello everyone!
    I am the assistant nurse manager at Hackensack UMC in Hackensack, NJ and I am looking for documentation to support my inpatient unit’s 1:2 nurse:patient staffing ratio for blinatumomab, dinutuximab, and other biotherapy infusions.  I am in the process of conducting a literature search but not having much luck.  Would you mind sharing your hospital name and pediatric biotherapy infusion staffing ratios (specifically blina & dinutux if possible)?  Also, if anyone has literature to support lower staffing ratios for these infusions I would sincerely appreciate it!  Thank you in advance!!

    Alyssa Henderson, RN, BSN, CPHON
    Inpatient Peds Heme/Onc/BMT Assistant Nurse Manager
    Hackensack, NJ